Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy, safety, and pharmacokinetics of LP-003 injection in patients with allergic asthma, and it is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LP-003 Injection (LP-003)

Snippet

Sponsor: Longbio Pharma | Conditions: Allergic Asthma | Phase 2 | Status: RECRUITING